ClinicalTrials.Veeva

Menu

Closed Incisional Negative Pressure Wound Therapy in Post-surgical Wound Care of Patients With Periprosthetic Joint Infection

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Enrolling

Conditions

Periprosthetic Joint Infection
Wound Heal

Treatments

Device: PREVENA incision management system

Study type

Interventional

Funder types

Other

Identifiers

NCT05357287
XMRPG3L1721

Details and patient eligibility

About

In the proposed study, we will apply Prevena on the surgical wound right after closure of the wound in the operating theater. Prevena will be used for 7 days, unless there is ongoing infection or much wound drainage that requires debridement.

Most periprosthetic joint infections are from hematogenous origin. Hence, it is considered clean wound unless there is a discharging sinus.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. patients with periprosthetic joint infection
  2. indicated for debridement surgery
  3. high risk for wound complication, including one of the followings: diabetes mellitus, use anticoagulants other than aspirin, current smoker, on immunomodulators or steroids, malnutrition, liver disease, renal failure, BMI > 35 kg/m2

Exclusion criteria

  1. previous flap surgery on the indexed joint
  2. younger than 18 years of age
  3. silver allergy

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

70 participants in 1 patient group

Prevena
Experimental group
Treatment:
Device: PREVENA incision management system

Trial contacts and locations

1

Loading...

Central trial contact

Sheng-Hsun Lee

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems